Advanced Metastatic Triple-negative Breast Cancer (mTNBC) Clinical Trials in Jinan, Shandong

A Prospective, Open-label, Single-arm, Exploratory Clinical Trial to Evaluate the Safety and Tolerability of 225Ac-TR2205 Injection in Patients With Triple-negative Breast Cancer.